Sphingosine kinase 2 (SPK2): the model showed that, compared to baseline, there was a significant increase in the level at 1 h post-hypoglycaemia (p = 0.011) in the T2D group compared to the control group. This evidence concerns the gene SPHK2 and type 2 diabetes mellitus.